Moderna is a pioneer in the revolutionary new field of RNA therapetutics – a technology which allows the human body to help heal itself. No only are they delivering a new technology, but they're doing it in a novel way. Remember Wyeth Pharmaceuticals? They took 4-7 years to discover a new drug target and begin preclinical testing. Moderna does it in a matter of weeks.
EnerNOC utilizes an operating model focused on technology, R&D, acquisition and partnership to carve out a category for energy intelligence software (EIS).
Valeant Pharmaceuticals has introduced a new operating model in R&D based on mergers and premium pricing. Is it sustainable?